Skip to main content

Peer Review reports

From: Clinical outcomes of switching to aflibercept using a pro re nata treatment regimen in patients with neovascular age-related macular degeneration who incompletely responded to ranibizumab

Original Submission
4 Oct 2017 Submitted Original manuscript
28 Oct 2017 Author responded Author comments - Flora Elwes
Resubmission - Version 2
28 Oct 2017 Submitted Manuscript version 2
12 Nov 2017 Reviewed Reviewer Report - Ta-Ching Chen
18 Nov 2017 Reviewed Reviewer Report - Jian Li
17 Dec 2017 Author responded Author comments - Flora Elwes
Resubmission - Version 3
17 Dec 2017 Submitted Manuscript version 3
22 Dec 2017 Reviewed Reviewer Report - Jian Li
31 Dec 2017 Reviewed Reviewer Report - Ta-Ching Chen
18 Jan 2018 Author responded Author comments - Flora Elwes
Resubmission - Version 4
18 Jan 2018 Submitted Manuscript version 4
Publishing
22 Jan 2018 Editorially accepted
30 Jan 2018 Article published 10.1186/s12886-018-0688-3

You can find further information about peer review here.

Back to article page